Page last updated: 2024-08-25

bexarotene and Protein Aggregation, Pathological

bexarotene has been researched along with Protein Aggregation, Pathological in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chia, S; Habchi, J; Horne, RI; Knowles, TPJ; Ruggeri, FS; Vendruscolo, M	1
Mahadevan, L; Michaels, TCT; Weber, CA	1

Other Studies

2 other study(ies) available for bexarotene and Protein Aggregation, Pathological

Article	Year
Infrared nanospectroscopy reveals the molecular interaction fingerprint of an aggregation inhibitor with single Aβ42 oligomers. Nature communications, 2021, 01-29, Volume: 12, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Bexarotene; Drug Discovery; Feasibility Studies; Humans; Hydrogen Bonding; Kinetics; Microscopy, Atomic Force; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Recombinant Proteins; Single Molecule Imaging; Spectrophotometry, Infrared; Structure-Activity Relationship; Vibration	2021
Optimal control strategies for inhibition of protein aggregation. Proceedings of the National Academy of Sciences of the United States of America, 2019, 07-16, Volume: 116, Issue:29 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Bexarotene; Caenorhabditis elegans; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Humans; Kinetics; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Time Factors	2019

Article

Year

Infrared nanospectroscopy reveals the molecular interaction fingerprint of an aggregation inhibitor with single Aβ42 oligomers.

Nature communications, 2021, 01-29, Volume: 12, Issue:1

Topics: Alzheimer Disease; Amyloid beta-Peptides; Bexarotene; Drug Discovery; Feasibility Studies; Humans; Hydrogen Bonding; Kinetics; Microscopy, Atomic Force; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Recombinant Proteins; Single Molecule Imaging; Spectrophotometry, Infrared; Structure-Activity Relationship; Vibration

2021

Optimal control strategies for inhibition of protein aggregation.

Proceedings of the National Academy of Sciences of the United States of America, 2019, 07-16, Volume: 116, Issue:29

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Bexarotene; Caenorhabditis elegans; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Humans; Kinetics; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Time Factors

2019